Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
News|Articles|July 14, 2016
Latest Business and People News
Updated employee announcements, business news and recognition in the industry today.
Advertisement
People
SCORR Marketing, a global health science marketing and communications firm, has announced the addition of three employees--Cliff Echols as market intelligence director; and Kerry Hutchings and Cherie Squires as senior directors of program management.
TFS International, a Sweden-based, global mid-size CRO, has appointed Birgitte Volck, MD, PhD, as a non-executive Director to serve on the Company's Board of Directors. Dr. Volck is the Senior Vice President, Head of R&D Rare Disease at GlaxoSmithKline in the UK. Schulman IRB, a central IRB, announced Michele Russell-Einhorn, JD, will join the organization September 1, 2016, as Vice President for Oncology Services. Russell-Einhorn currently is Senior Director of Dana-Farber Cancer Institute’s Office for Human Research Studies. At Schulman IRB, she will build and lead the company’s forthcoming Central Oncology Review (COR) division, launching later in 2016.
Business News Dr Rabinder Buttar, founder and CEO of ClinTec International, joined an industry-leading expert panel of judges for the eighth round final of the Scottish EDGE competition, which identifies and supports Scotland’s up-and-coming, innovative, high-growth generating entrepreneurial talent. Recognition Q2 Solutions, a global clinical trials laboratory services organization and joint venture of Quest and Quintiles, has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts. ClinCapture, a provider of free and validated electronic data capture (EDC) software, announced its nomination for a Bronze 2016 Stevie Award by the American Business Awardsâ in the Cloud Application/Service as well as the Software Development Solution Website category.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
2
Bipartisan Bill Would Build Reusable Clinical Trial Networks, With a Focus on Rare Disease
3
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
4
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
5